Nancy Y. Lee, MD, FASTRO - MSK ...

Dr. Nancy Lee, MD

Claim this profile

Memorial Sloan Kettering Cancer Center

Studies Head and Neck Cancers
Studies Squamous Cell Carcinoma
14 reported clinical trials
31 drugs studied

Area of expertise

1

Head And Neck Cancers

Nancy Lee, MD has run 5 trials for Head and Neck Cancers.

2

Squamous Cell Carcinoma

Nancy Lee, MD has run 4 trials for Squamous Cell Carcinoma. Some of their research focus areas include:

Stage III
Stage IV
p16 negative

Affiliated Hospitals

Image of trial facility.

Memorial Sloan Kettering Cancer Center

Image of trial facility.

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

Clinical Trials Nancy Lee, MD is currently running

Image of trial facility.

RP-3500 + Radiation Therapy

for Cancer

The purpose of this study is to test the safety of the study drug, RP-3500 when given in combination with palliative external beam radiotherapy (EBRT) to people who have metastatic solid tumor cancer with a mutation of the ATM gene. The study researchers will do tests to find the highest dose of RP3500 that causes few or mild side effects.

Recruiting

1 award

Phase 1 & 2

Image of trial facility.

Chemotherapy + Radiation Therapy

for Head and Neck Cancer

This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.

Recruiting

1 award

Phase 2 & 3

21 criteria

More about Nancy Lee, MD

Clinical Trial Related

2 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical Trials

Treatments Nancy Lee, MD has experience with

  • Cisplatin
  • Intensity-Modulated Radiation Therapy
  • Carboplatin
  • Proton Therapy
  • Telemedicine Surveillance (tele-surveillance)
  • Questionnaires

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Nancy Lee, MD specialize in?

Is Nancy Lee, MD currently recruiting for clinical trials?

Are there any treatments that Nancy Lee, MD has studied deeply?

What is the best way to schedule an appointment with Nancy Lee, MD?

What is the office address of Nancy Lee, MD?

Is there any support for travel costs?

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Terms of Service·Privacy Policy·Cookies·Security